Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Fish and Richardson
Queensland Health
Chinese Patent Office
Merck
Accenture
Cantor Fitzgerald
Federal Trade Commission

Generated: April 19, 2018

DrugPatentWatch Database Preview

SECONAL SODIUM Drug Profile

« Back to Dashboard

When do Seconal Sodium patents expire, and when can generic versions of Seconal Sodium launch?

Seconal Sodium is a drug marketed by Valeant Pharms North and Lilly and is included in three NDAs.

The generic ingredient in SECONAL SODIUM is secobarbital sodium. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the secobarbital sodium profile page.
Drug patent expirations by year for SECONAL SODIUM
Medical Subject Heading (MeSH) Categories for SECONAL SODIUM
Synonyms for SECONAL SODIUM
(.+/-.))-Secobarbital
(+-)-5-Allyl-5-(1-methylbutyl)-barbituric acid
(+-)-Secobarbital
(+/-)-Quinalbarbitone
(+/-)-Secobarbital
(RS)-Secobarbital
[(Propylmethylcarbinyl)allyl] barbituric acid sodium salt
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-methylbutyl)-5-(2-propen-1-yl)-
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-methylbutyl)-5-(2-propenyl)-
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-methylbutyl)-5-(2-propenyl)-, (+-)-
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-methylbutyl)-5-(2-propenyl)-, (+-)- (9CI)
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-methylbutyl)-5-(2-propenyl)-, (+-)-(9CI)
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-methylbutyl)-5-(2-propenyl)-, monosodium salt
2,4,6(1H,3H,5H)-Pyrimidinitrione, 5-(1-methylbutyl)-5-(2-propenyl)-
2,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-methylbutyl)-5-(2-propenyl)-, monosodium salt
29071-21-4
309-43-3
5-(1-Methylbutyl)-5-(2-propen-1-yl)-2,4,6(1H,3H,5H)-pyrimidinetrione
5-(1-methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione
5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione monosodium salt
5-(pentan-2-yl)-5-(prop-2-en-1-yl)-1,3-diazinane-2,4,6-trione
5-(pentan-2-yl)-5-(prop-2-en-1-yl)-pyrimidine-2,4,6(1H,3H,5H)-trione
5-24-09-00235 (Beilstein Handbook Reference)
5-allyl-(1-methyl-butyl)-barbituric acid
5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione
5-Allyl-5-(1-methylbutyl)barbiturate
5-ALLYL-5-(1-METHYLBUTYL)BARBITURIC ACID
5-Allyl-5-(1-methylbutyl)barbituric acid sodium salt
5-Allyl-5-(1-methylbutyl)barbituric acid, sodium salt
5-Allyl-5-(1-methylbutyl)malonylurea
5-Allyl-5-(1-methylbutyl)malonylurea sodium salt
5-allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione
5-Allyl-5(1-methylbutyl)barbituric acid sodium derivative
5-pentan-2-yl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione
76-73-3
AC1L1JT0
AC1Q2UJO
AN-23386
API0004149
AXXJTNXVUHVOJW-UHFFFAOYSA-M
Barbituric acid, 5-allyl-5-(1-methylbutyl)-
BARBITURIC ACID, 5-ALLYL-5-(1-METHYLBUTYL)-, (+-)-
BARBITURIC ACID, 5-ALLYL-5-(1-METHYLBUTYL)-, SODIUM SALT
Barbosec
Bipanal
Bipinal sodium
BRN 0225330
C12H17N2O3.Na
C12H18N2O3
CHEBI:9073
CHEMBL1200903
CHEMBL447
D00430
D00SJE
D01310
DB00418
DEA No. 2315
DEA No. 2316
Dormatylan
Dormona
DTXSID6044145
EINECS 200-982-2
EINECS 206-218-4
Evronal
Evronal sodium
Evrronal
GTPL7615
HE009877
HE051189
HE332270
HE333921
HSDB 3182
Hypotrol
Hyptran
Hyptran (Salt/Mix)
Imesonal
Imesonal (Salt/Mix)
Immenoctal
Immenoctal (Salt/Mix)
Immenox
KQPKPCNLIDLUMF-UHFFFAOYSA-N
LS-23756
LS-23757
LS-23761
Meballymal
Meballymal sodium
Meballymalum
NCGC00247712-01
NSC 10818
NSC-10818
NSC10818
Pramil
Propylmethylcarbinylallyl barbituric acid sodium salt
Quinalbarbital
Quinalbarbitone
Quinalbarbitone sodium
Quinalspan
quinobarbitone
S0223
SCHEMBL11110602
SCHEMBL80734
Sebar
Seco 8
secobarbital
Secobarbital (USP/INN)
Secobarbital [USAN:INN]
Secobarbital 0.1 mg/ml in Methanol
Secobarbital 1.0 mg/ml in Methanol
Secobarbital 4-sodium
Secobarbital sodium
Secobarbital sodium (JAN/USP)
Secobarbital sodium [USAN:JAN]
Secobarbital sodium [USP:INN:BAN:JAN]
SECOBARBITAL SODIUM, USP
Secobarbital solution
Secobarbital solution, 1 mg/mL in methanol, ampule of 1 mL, certified reference material
Secobarbital solution, 1.0 mg/mL in methanol, analytical standard, for drug analysis
Secobarbital suppository dosage form
Secobarbital suppository dosage form [DEA No. 2316]
Secobarbital, analytical standard
Secobarbital, sodium salt
Secobarbital, United States Pharmacopeia (USP) Reference Standard
SECOBARBITAL,1.0MG/MLINMETHANOL
Secobarbitale
Secobarbitale [DCIT]
Secobarbitalum
Secobarbitalum [INN-Latin]
Secobarbitone
Secobarbitone sodium
Seconal
Seconal (TN)
Seconal sodium (TN)
Sedutain
Seotal
sodium 2,4,6-trioxo-5-(pentan-2-yl)-5-(prop-2-en-1-yl)-1,3-diazinan-1-ide
sodium 5-(1-methylbutyl)-4,6-dioxo-5-prop-2-en-1-yl-1,4,5,6-tetrahydropyrimidin-2-olate
sodium 5-allyl-5-(1-methylbutyl)-4,6-dioxo-1,4,5,6-tetrahydropyrimidin-2-olate
Sodium 5-allyl-5-(1-methylbutyl)barbiturate
sodium 5-allyl-5-(1-methylbutyl)hexahydropyrimidin-3-ide-2,4,6-trione
Sodium quinalbarbitone
Sodium secobarbital
Sodium seconal
Somatarax
Somosal
Synate
Trisomnin
Trisomnin (Salt/Mix)
WLN: T6VMVMV FHJ FY3 & 1 F2U1 &-NA-

US Patents and Regulatory Information for SECONAL SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Pharms North SECONAL SODIUM secobarbital sodium CAPSULE;ORAL 086101-001 Oct 3, 1983 RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lilly SECONAL SODIUM secobarbital sodium SUPPOSITORY;RECTAL 086530-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lilly SECONAL SODIUM secobarbital sodium SUPPOSITORY;RECTAL 086530-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharms North SECONAL SODIUM secobarbital sodium CAPSULE;ORAL 086101-002 Oct 3, 1983 RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Federal Trade Commission
Citi
UBS
Accenture
Express Scripts
Merck
Cipla
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.